In support of this hypothesis, the authors found that the systemic treatment of CP mice with LDN-212320, an agonist of GLT-1, alleviated the hyperactivity of glutamatergic neurons in the PVN, as well as the abdominal pain and anxiety-like behavior in these mice. This evidence concerns the gene SLC1A2 and Anxiety.